Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II ...

Add Yahoo as a preferred source to see more of our stories on Google. If you’re one of the millions of people who have a gaping space in your gums where a tooth used to be, there’s reason to hope you ...

This could be a game changer. The post Plans Accelerated for Human Trials of Tooth Regeneration appeared first on Futurism.

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in genetics, molecular biology, and regenerative medicine, that dream is ...

First highlighted as part of a study in 2021, a tooth-regrowing drug is set to finally enter human testing this year. We covered plans for the drug to come to clinical trials last year, and now, it ...

Tooth regrowth drug TRG035 is moving towards Phase II trials in patients with severe congenital hypodontia after new funding.

It may very well be possible to grow new teeth sometime in the future. In fact, a Japanese company working on a tooth-growing drug is just now slated to enter clinical trials, making it the world's ...

Japan's TRG-035 drug targets tooth regrowth proteins in human trials, offering hope for dental replacement beyond implants by ...

Add Futurism (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.